HEADER HYDROLASE/TRANSFERASE 13-JAN-00 1DTT
TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-
TITLE 2 2 (PETT130A94)
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIV-1 RT A-CHAIN;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: P66;
COMPND 5 ENGINEERED: YES;
COMPND 6 MOL_ID: 2;
COMPND 7 MOLECULE: HIV-1 RT B-CHAIN;
COMPND 8 CHAIN: B;
COMPND 9 FRAGMENT: P51;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 EXPRESSION_SYSTEM: BACTERIA;
SOURCE 5 EXPRESSION_SYSTEM_COMMON: EUBACTERIA;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 2;
SOURCE 7 MOL_ID: 2;
SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 9 ORGANISM_TAXID: 11676;
SOURCE 10 EXPRESSION_SYSTEM: BACTERIA;
SOURCE 11 EXPRESSION_SYSTEM_COMMON: EUBACTERIA;
SOURCE 12 EXPRESSION_SYSTEM_TAXID: 2
KEYWDS HIV-1 REVERSE TRANSCRIPTASE AIDS, NON-NUCLEOSIDE INHIBITOR, DRUG
KEYWDS 2 DESIGN, HYDROLASE-TRANSFERASE COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.REN,J.DIPROSE,J.WARREN,R.M.ESNOUF,L.E.BIRD,S.IKEMIZU,M.SLATER,
AUTHOR 2 J.MILTON,J.BALZARINI,D.I.STUART,D.K.STAMMERS
REVDAT 3 12-NOV-14 1DTT 1 HET HETATM HETNAM HETSYN
REVDAT 3 2 1 MODRES FORMUL REMARK VERSN
REVDAT 3 3 1 LINK SEQRES JRNL
REVDAT 2 24-FEB-09 1DTT 1 VERSN
REVDAT 1 02-APR-00 1DTT 0
JRNL AUTH J.REN,J.DIPROSE,J.WARREN,R.M.ESNOUF,L.E.BIRD,S.IKEMIZU,
JRNL AUTH 2 M.SLATER,J.MILTON,J.BALZARINI,D.I.STUART,D.K.STAMMERS
JRNL TITL PHENYLETHYLTHIAZOLYLTHIOUREA (PETT) NON-NUCLEOSIDE
JRNL TITL 2 INHIBITORS OF HIV-1 AND HIV-2 REVERSE TRANSCRIPTASES.
JRNL TITL 3 STRUCTURAL AND BIOCHEMICAL ANALYSES.
JRNL REF J.BIOL.CHEM. V. 275 5633 2000
JRNL REFN ISSN 0021-9258
JRNL PMID 10681546
JRNL DOI 10.1074/JBC.275.8.5633
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH J.REN,R.M.ESNOUF,A.L.HOPKINS,D.I.STUART,D.K.STAMMERS
REMARK 1 TITL CRYSTALLOGRAPHIC ANALYSIS OF THE BINDING MODES OF
REMARK 1 TITL 2 THIAZOLOISOINDOLINONE NON-NUCLEOSIDE INHIBITORS TO HIV-1
REMARK 1 TITL 3 REVERSE TRANSCRIPTASE AND COMPARISON WITH MODELING STUDIES.
REMARK 1 REF J.MED.CHEM. V. 42 3845 1999
REMARK 1 REFN ISSN 0022-2623
REMARK 1 PMID 10508433
REMARK 1 DOI 10.1021/JM990275T
REMARK 1 REFERENCE 2
REMARK 1 AUTH A.L.HOPKINS,J.REN,H.TANAKA,M.BABA,M.OKAMATO,D.I.STUART,
REMARK 1 AUTH 2 D.K.STAMMERS
REMARK 1 TITL DESIGN OF MKC-442 (EMIVIRINE) ANALOGUES WITH IMPROVED
REMARK 1 TITL 2 ACTIVITY AGAINST DRUG-RESISTANT HIV MUTANTS.
REMARK 1 REF J.MED.CHEM. V. 42 4500 1999
REMARK 1 REFN ISSN 0022-2623
REMARK 1 PMID 10579814
REMARK 1 DOI 10.1021/JM990192C
REMARK 1 REFERENCE 3
REMARK 1 AUTH J.REN,R.M.ESNOUF,A.L.HOPKINS,J.WARREN,J.BALZARINI,
REMARK 1 AUTH 2 D.I.STUART,D.K.STAMMERS
REMARK 1 TITL CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX
REMARK 1 TITL 2 WITH CARBOXANILIDE DERIVATIVES.
REMARK 1 REF BIOCHEMISTRY V. 37 14394 1998
REMARK 1 REFN ISSN 0006-2960
REMARK 1 PMID 9772165
REMARK 1 DOI 10.1021/BI981309M
REMARK 1 REFERENCE 4
REMARK 1 AUTH J.REN,R.M.ESNOUF,A.L.HOPKINS,E.Y.JONES,I.KIRBY,J.KEELING,
REMARK 1 AUTH 2 C.K.ROSS,B.A.LARDER,D.I.STUART,D.K.STAMMERS
REMARK 1 TITL 3'-AZIDO-3'-DEOXYTHYMIDINE DRUG RESISTANCE MUTATIONS IN
REMARK 1 TITL 2 HIV-1 REVERSE TRANSCRIPTASE CAN INDUCE LONG RANGE
REMARK 1 TITL 3 CONFORMATIONAL CHANGES.
REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 95 9518 1998
REMARK 1 REFN ISSN 0027-8424
REMARK 1 PMID 9689112
REMARK 1 DOI 10.1073/PNAS.95.16.9518
REMARK 1 REFERENCE 5
REMARK 1 AUTH R.M.ESNOUF,J.REN,E.F.GARMAN,D.O.SOMERS,C.K.ROSS,E.Y.JONES,
REMARK 1 AUTH 2 D.K.STAMMERS,D.I.STUART
REMARK 1 TITL CONTINUOUS AND DISCONTINUOUS CHANGES IN THE UNIT CELL OF
REMARK 1 TITL 2 HIV-1 REVERSE TRANSCRIPTASE CRYSTALS ON DEHYDRATION.
REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 54 938 1998
REMARK 1 REFN ISSN 0907-4449
REMARK 1 PMID 9757109
REMARK 1 DOI 10.1107/S0907444998004284
REMARK 1 REFERENCE 6
REMARK 1 AUTH R.M.ESNOUF,J.REN,A.L.HOPKINS,C.K.ROSS,E.Y.JONES,
REMARK 1 AUTH 2 D.K.STAMMERS,D.I.STUART
REMARK 1 TITL UNIQUE FEATURES IN THE STRUCTURE OF THE COMPLEX BETWEEN
REMARK 1 TITL 2 HIV-1 REVERSE TRANSCRIPTASE AND THE
REMARK 1 TITL 3 BIS(HETEROARYL)PIPERAZINE (BHAP) U-90152 EXPLAIN RESISTANCE
REMARK 1 TITL 4 MUTATIONS FOR THIS NONNUCLEOSIDE INHIBITOR.
REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 94 3984 1997
REMARK 1 REFN ISSN 0027-8424
REMARK 1 PMID 9108091
REMARK 1 DOI 10.1073/PNAS.94.8.3984
REMARK 1 REFERENCE 7
REMARK 1 AUTH A.L.HOPKINS,J.REN,R.M.ESNOUF,B.E.WILLCOX,E.Y.JONES,C.ROSS,
REMARK 1 AUTH 2 T.MIYASAKA,R.T.WALKER,H.TANAKA,D.K.STAMMERS,D.I.STUART
REMARK 1 TITL COMPLEXES OF HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITORS OF
REMARK 1 TITL 2 THE HEPT SERIES REVEAL CONFORMATIONAL CHANGES RELEVANT TO
REMARK 1 TITL 3 THE DESIGN OF POTENT NON-NUCLEOSIDE INHIBITORS.
REMARK 1 REF J.MED.CHEM. V. 39 1589 1996
REMARK 1 REFN ISSN 0022-2623
REMARK 1 PMID 8648598
REMARK 1 DOI 10.1021/JM960056X
REMARK 1 REFERENCE 8
REMARK 1 AUTH J.REN,R.ESNOUF,A.HOPKINS,C.ROSS,Y.JONES,D.STAMMERS,D.STUART
REMARK 1 TITL THE STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH
REMARK 1 TITL 2 9-CHLORO-TIBO: LESSONS FOR INHIBITOR DESIGN.
REMARK 1 REF STRUCTURE V. 3 915 1995
REMARK 1 REFN ISSN 0969-2126
REMARK 1 PMID 8535785
REMARK 1 DOI 10.1021/JM990275T
REMARK 1 REFERENCE 9
REMARK 1 AUTH J.REN,R.ESNOUF,E.GARMAN,D.SOMERS,C.ROSS,I.KIRBY,J.KEELING,
REMARK 1 AUTH 2 G.DARBY,Y.JONES,D.STUART
REMARK 1 TITL HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR
REMARK 1 TITL 2 RT-INHIBITOR COMPLEXES.
REMARK 1 REF NAT.STRUCT.BIOL. V. 2 293 1995
REMARK 1 REFN ISSN 1072-8368
REMARK 1 PMID 7540934
REMARK 1 DOI 10.1021/JM990192C
REMARK 1 REFERENCE 10
REMARK 1 AUTH R.ESNOUF,J.REN,C.ROSS,Y.JONES,D.STAMMERS,D.STUART
REMARK 1 TITL MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY
REMARK 1 TITL 2 NON-NUCLEOSIDE INHIBITORS.
REMARK 1 REF NAT.STRUCT.BIOL. V. 2 303 1995
REMARK 1 REFN ISSN 1072-8368
REMARK 1 PMID 7540935
REMARK 1 DOI 10.1021/BI981309M
REMARK 1 REFERENCE 11
REMARK 1 AUTH D.K.STAMMERS,D.O.SOMERS,C.K.ROSS,I.KIRBY,P.H.RAY,J.E.WILSON,
REMARK 1 AUTH 2 M.NORMAN,J.S.REN,R.M.ESNOUF,E.F.GARMAN
REMARK 1 TITL CRYSTALS OF HIV-1 REVERSE TRANSCRIPTASE DIFFRACTING TO 2.2 A
REMARK 1 TITL 2 RESOLUTION.
REMARK 1 REF J.MOL.BIOL. V. 242 586 1994
REMARK 1 REFN ISSN 0022-2836
REMARK 1 PMID 7523679
REMARK 1 DOI 10.1073/PNAS.95.16.9518
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.5
REMARK 3 NUMBER OF REFLECTIONS : 20940
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.199
REMARK 3 FREE R VALUE : 0.276
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : 1013
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 7828
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 23
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS:
REMARK 3 DUE TO THE LOW RATIO BETWEEN THE NUMBER OF
REMARK 3 REFLECTIONS AND THE NUMBER OF PARAMETERS TO BE
REMARK 3 REFINED, POSITIONAL RESTRAINTS WERE APPLIED TO ALL
REMARK 3 ATOMS DISTANT FROM THE NNRTI-BINDING SITE (DEFINED AS
REMARK 3 GREATER THAN 25 ANSTROM FROM THE CA ATOM OF RESIDUE
REMARK 3 188) THROUGHOUT THE REFINEMENT.
REMARK 4
REMARK 4 1DTT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JAN-00.
REMARK 100 THE RCSB ID CODE IS RCSB010359.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-JAN-96; 01-JAN-96
REMARK 200 TEMPERATURE (KELVIN) : 288; 288
REMARK 200 PH : 5
REMARK 200 NUMBER OF CRYSTALS USED : 2
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y; Y
REMARK 200 RADIATION SOURCE : PHOTON FACTORY; PHOTON FACTORY
REMARK 200 BEAMLINE : BL-6A; BL-6A
REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; NULL
REMARK 200 WAVELENGTH OR RANGE (A) : 1.000; 1.000
REMARK 200 MONOCHROMATOR : NULL; NULL
REMARK 200 OPTICS : NULL; NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE; IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : FUJI; FUJI
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21409
REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.500
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.2
REMARK 200 DATA REDUNDANCY : 4.200
REMARK 200 R MERGE (I) : 0.09500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.7
REMARK 200 DATA REDUNDANCY IN SHELL : 3.00
REMARK 200 R MERGE FOR SHELL (I) : 0.59200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.09
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: SEE REFERENCE 11, PH 5, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 70.35000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.70000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.40000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.70000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.35000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.40000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5780 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 46750 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 PRO A 140
REMARK 465 GLY A 141
REMARK 465 GLY A 544
REMARK 465 ASN A 545
REMARK 465 GLU A 546
REMARK 465 GLN A 547
REMARK 465 VAL A 548
REMARK 465 ASP A 549
REMARK 465 LYS A 550
REMARK 465 LEU A 551
REMARK 465 VAL A 552
REMARK 465 SER A 553
REMARK 465 ALA A 554
REMARK 465 GLY A 555
REMARK 465 ILE A 556
REMARK 465 ARG A 557
REMARK 465 LYS A 558
REMARK 465 VAL A 559
REMARK 465 LEU A 560
REMARK 465 PRO B 1
REMARK 465 ILE B 2
REMARK 465 SER B 3
REMARK 465 PRO B 4
REMARK 465 GLU B 89
REMARK 465 VAL B 90
REMARK 465 GLN B 91
REMARK 465 ASP B 218
REMARK 465 LYS B 219
REMARK 465 LYS B 220
REMARK 465 HIS B 221
REMARK 465 GLN B 222
REMARK 465 LYS B 223
REMARK 465 GLU B 224
REMARK 465 PRO B 225
REMARK 465 PRO B 226
REMARK 465 PHE B 227
REMARK 465 LEU B 228
REMARK 465 TRP B 229
REMARK 465 MET B 230
REMARK 465 PRO B 433
REMARK 465 ILE B 434
REMARK 465 VAL B 435
REMARK 465 GLY B 436
REMARK 465 ALA B 437
REMARK 465 GLU B 438
REMARK 465 THR B 439
REMARK 465 PHE B 440
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 4 51.82 -90.34
REMARK 500 PRO A 19 171.26 -40.65
REMARK 500 LYS A 20 9.22 -153.63
REMARK 500 PRO A 25 151.39 -39.41
REMARK 500 VAL A 35 -71.02 -63.44
REMARK 500 GLU A 36 -6.21 -57.52
REMARK 500 ILE A 47 72.56 -52.64
REMARK 500 LYS A 49 124.05 160.12
REMARK 500 PRO A 52 -9.85 -36.58
REMARK 500 TYR A 56 65.77 -115.50
REMARK 500 LYS A 66 94.78 -29.96
REMARK 500 ASP A 67 8.21 147.45
REMARK 500 SER A 68 -34.87 -148.09
REMARK 500 LYS A 70 102.45 -163.82
REMARK 500 TRP A 71 107.61 -52.96
REMARK 500 LYS A 73 158.53 -26.94
REMARK 500 ARG A 78 -50.33 -24.09
REMARK 500 GLN A 85 -175.04 -56.10
REMARK 500 PHE A 87 -162.35 -111.89
REMARK 500 GLU A 89 115.68 -31.81
REMARK 500 GLN A 91 69.73 80.40
REMARK 500 ALA A 98 -3.98 -56.70
REMARK 500 VAL A 111 42.68 -82.30
REMARK 500 ASP A 113 51.21 -65.09
REMARK 500 TYR A 127 19.48 -68.67
REMARK 500 PHE A 130 -165.12 -106.17
REMARK 500 THR A 131 101.68 176.89
REMARK 500 ILE A 132 71.75 -113.68
REMARK 500 SER A 134 -93.00 -49.42
REMARK 500 ILE A 135 -57.18 -143.03
REMARK 500 ASN A 136 -122.33 -80.91
REMARK 500 ASN A 137 -124.97 -95.68
REMARK 500 GLN A 145 -152.44 -146.42
REMARK 500 MET A 184 -128.00 58.18
REMARK 500 SER A 191 168.06 176.21
REMARK 500 ILE A 195 -60.30 -26.64
REMARK 500 LYS A 219 -14.79 -49.31
REMARK 500 TRP A 229 -143.19 -116.88
REMARK 500 MET A 230 72.79 -67.98
REMARK 500 GLN A 242 92.44 -55.50
REMARK 500 VAL A 276 7.95 -153.19
REMARK 500 THR A 286 126.35 -36.60
REMARK 500 PRO A 294 -113.76 -60.65
REMARK 500 LEU A 295 91.57 161.51
REMARK 500 LEU A 310 23.63 -63.95
REMARK 500 LYS A 311 -86.81 -85.39
REMARK 500 GLU A 312 107.59 -58.53
REMARK 500 PRO A 313 179.61 -47.44
REMARK 500 PHE A 346 -20.14 80.26
REMARK 500 MET A 357 -149.69 -80.29
REMARK 500
REMARK 500 THIS ENTRY HAS 104 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FTC A 999
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1RTV RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH NEVIRAPINE
REMARK 900 RELATED ID: 1RTH RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH 1051U91
REMARK 900 RELATED ID: 1VRU RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH ALPHA-APA
REMARK 900 RELATED ID: 1RTI RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH HEPT
REMARK 900 RELATED ID: 1RTJ RELATED DB: PDB
REMARK 900 HIV-1 RT
REMARK 900 RELATED ID: 1REV RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH 9-CL-TIBO
REMARK 900 RELATED ID: 1RT1 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH MKC-442
REMARK 900 RELATED ID: 1RT2 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH TNK-651
REMARK 900 RELATED ID: 1KLM RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH BHAP (U-90152)
REMARK 900 RELATED ID: 1RT3 RELATED DB: PDB
REMARK 900 AZT DRUG RESISTANT HIV-1 RT MUTANT (RTMC) COMPLEXED WITH
REMARK 900 1051U91
REMARK 900 RELATED ID: 1RT4 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH UC-781
REMARK 900 RELATED ID: 1RT5 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH UC-10
REMARK 900 RELATED ID: 1RT6 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH UC-38
REMARK 900 RELATED ID: 1RT7 RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH UC-84
REMARK 900 RELATED ID: 1C0T RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH BM+21.1326
REMARK 900 RELATED ID: 1C0U RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH BM+50.0934
REMARK 900 RELATED ID: 1C1B RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH GCA-186
REMARK 900 RELATED ID: 1C1C RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH TNK-6123
REMARK 900 RELATED ID: 1DTQ RELATED DB: PDB
REMARK 900 HIV-1 RT COMPLEXED WITH PETT-1
DBREF 1DTT A 1 560 UNP P04585 POL_HV1H2 587 1146
DBREF 1DTT B 1 440 UNP P04585 POL_HV1H2 587 1026
SEQRES 1 A 560 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS
SEQRES 2 A 560 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU
SEQRES 3 A 560 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR
SEQRES 4 A 560 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO
SEQRES 5 A 560 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS
SEQRES 6 A 560 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG
SEQRES 7 A 560 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN
SEQRES 8 A 560 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS
SEQRES 9 A 560 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER
SEQRES 10 A 560 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE
SEQRES 11 A 560 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG
SEQRES 12 A 560 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER
SEQRES 13 A 560 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU
SEQRES 14 A 560 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN
SEQRES 15 A 560 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE
SEQRES 16 A 560 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS
SEQRES 17 A 560 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS
SEQRES 18 A 560 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU
SEQRES 19 A 560 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO
SEQRES 20 A 560 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU
SEQRES 21 A 560 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY
SEQRES 22 A 560 ILE LYS VAL ARG GLN LEU CSD LYS LEU LEU ARG GLY THR
SEQRES 23 A 560 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA
SEQRES 24 A 560 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU
SEQRES 25 A 560 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU
SEQRES 26 A 560 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR
SEQRES 27 A 560 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR
SEQRES 28 A 560 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP
SEQRES 29 A 560 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR
SEQRES 30 A 560 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS
SEQRES 31 A 560 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR
SEQRES 32 A 560 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE
SEQRES 33 A 560 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU
SEQRES 34 A 560 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL
SEQRES 35 A 560 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA
SEQRES 36 A 560 GLY TYR VAL THR ASN ARG GLY ARG GLN LYS VAL VAL THR
SEQRES 37 A 560 LEU THR ASP THR THR ASN GLN LYS THR GLU LEU GLN ALA
SEQRES 38 A 560 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN
SEQRES 39 A 560 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN
SEQRES 40 A 560 ALA GLN PRO ASP GLN SER GLU SER GLU LEU VAL ASN GLN
SEQRES 41 A 560 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU
SEQRES 42 A 560 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU
SEQRES 43 A 560 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG LYS VAL
SEQRES 44 A 560 LEU
SEQRES 1 B 440 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS
SEQRES 2 B 440 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU
SEQRES 3 B 440 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR
SEQRES 4 B 440 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO
SEQRES 5 B 440 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS
SEQRES 6 B 440 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG
SEQRES 7 B 440 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN
SEQRES 8 B 440 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS
SEQRES 9 B 440 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER
SEQRES 10 B 440 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE
SEQRES 11 B 440 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG
SEQRES 12 B 440 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER
SEQRES 13 B 440 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU
SEQRES 14 B 440 PRO PHE ARG LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN
SEQRES 15 B 440 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE
SEQRES 16 B 440 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS
SEQRES 17 B 440 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS
SEQRES 18 B 440 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU
SEQRES 19 B 440 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO
SEQRES 20 B 440 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU
SEQRES 21 B 440 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY
SEQRES 22 B 440 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR
SEQRES 23 B 440 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA
SEQRES 24 B 440 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU
SEQRES 25 B 440 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU
SEQRES 26 B 440 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR
SEQRES 27 B 440 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR
SEQRES 28 B 440 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP
SEQRES 29 B 440 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR
SEQRES 30 B 440 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS
SEQRES 31 B 440 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR
SEQRES 32 B 440 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE
SEQRES 33 B 440 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU
SEQRES 34 B 440 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE
MODRES 1DTT CSD A 280 CYS 3-SULFINOALANINE
HET CSD A 280 8
HET FTC A 999 23
HETNAM CSD 3-SULFINOALANINE
HETNAM FTC N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-
HETNAM 2 FTC PYRIDYL]-THIOUREA
HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE
FORMUL 1 CSD C3 H7 N O4 S
FORMUL 3 FTC C15 H16 CL F N4 O S
HELIX 1 1 THR A 27 GLY A 45 1 19
HELIX 2 2 PHE A 77 ARG A 83 1 7
HELIX 3 3 HIS A 96 LEU A 100 5 5
HELIX 4 4 GLY A 112 VAL A 118 5 7
HELIX 5 5 ASP A 121 LYS A 126 1 6
HELIX 6 6 LYS A 154 ASN A 175 1 22
HELIX 7 7 GLU A 194 ARG A 211 1 18
HELIX 8 8 ASP A 218 GLN A 222 5 5
HELIX 9 9 THR A 253 GLN A 269 1 17
HELIX 10 10 THR A 296 LEU A 310 1 15
HELIX 11 11 ASN A 363 GLY A 384 1 22
HELIX 12 12 GLN A 394 THR A 403 1 10
HELIX 13 13 THR A 473 ASP A 488 1 16
HELIX 14 14 SER A 499 ALA A 508 1 10
HELIX 15 15 SER A 515 LYS A 528 1 14
HELIX 16 16 THR B 27 GLU B 44 1 18
HELIX 17 17 PHE B 77 THR B 84 1 8
HELIX 18 18 ALA B 98 LYS B 103 1 6
HELIX 19 19 VAL B 111 VAL B 118 1 8
HELIX 20 20 ASP B 121 LYS B 126 1 6
HELIX 21 21 TYR B 127 ALA B 129 5 3
HELIX 22 22 SER B 134 GLU B 138 5 5
HELIX 23 23 LYS B 154 LYS B 173 1 20
HELIX 24 24 GLU B 194 GLY B 213 1 20
HELIX 25 25 HIS B 235 TRP B 239 5 5
HELIX 26 26 VAL B 254 SER B 268 1 15
HELIX 27 27 VAL B 276 LEU B 283 1 8
HELIX 28 28 THR B 296 LYS B 311 1 16
HELIX 29 29 ASN B 363 GLY B 384 1 22
HELIX 30 30 GLN B 394 TRP B 406 1 13
HELIX 31 31 PRO B 420 LEU B 429 1 10
SHEET 1 A 3 SER A 105 ASP A 110 0
SHEET 2 A 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109
SHEET 3 A 3 ILE A 178 TYR A 183 -1 O VAL A 179 N GLY A 190
SHEET 1 B 4 PHE A 227 LEU A 228 0
SHEET 2 B 4 TYR A 232 LEU A 234 -1 N LEU A 234 O PHE A 227
SHEET 3 B 4 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233
SHEET 4 B 4 VAL A 314 GLY A 316 -1 O VAL A 314 N VAL A 241
SHEET 1 C 5 LYS A 347 ALA A 355 0
SHEET 2 C 5 GLN A 336 GLU A 344 -1 N TRP A 337 O TYR A 354
SHEET 3 C 5 ILE A 326 GLY A 333 -1 N ILE A 326 O TYR A 342
SHEET 4 C 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327
SHEET 5 C 5 TRP A 414 PHE A 416 1 N GLU A 415 O PHE A 389
SHEET 1 D 3 GLU A 438 TYR A 441 0
SHEET 2 D 3 GLU A 492 THR A 497 1 O GLU A 492 N GLU A 438
SHEET 3 D 3 LYS A 530 TRP A 535 1 O LYS A 530 N VAL A 493
SHEET 1 E 3 ASP A 443 ALA A 446 0
SHEET 2 E 3 LEU A 452 VAL A 458 -1 N LYS A 454 O ALA A 445
SHEET 3 E 3 GLN A 464 THR A 470 -1 O LYS A 465 N TYR A 457
SHEET 1 F 3 ILE B 47 LYS B 49 0
SHEET 2 F 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48
SHEET 3 F 3 PHE B 130 ILE B 132 -1 O PHE B 130 N TYR B 144
SHEET 1 G 2 VAL B 60 LYS B 64 0
SHEET 2 G 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63
SHEET 1 H 3 SER B 105 ASP B 110 0
SHEET 2 H 3 ASP B 186 SER B 191 -1 O LEU B 187 N LEU B 109
SHEET 3 H 3 VAL B 179 TYR B 183 -1 N VAL B 179 O GLY B 190
SHEET 1 I 2 TRP B 252 THR B 253 0
SHEET 2 I 2 VAL B 292 ILE B 293 -1 N ILE B 293 O TRP B 252
SHEET 1 J 5 ASN B 348 ALA B 355 0
SHEET 2 J 5 GLN B 336 TYR B 342 -1 O TRP B 337 N TYR B 354
SHEET 3 J 5 ILE B 326 GLY B 333 -1 N ILE B 326 O TYR B 342
SHEET 4 J 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327
SHEET 5 J 5 TRP B 414 PHE B 416 1 N GLU B 415 O PHE B 389
LINK C LEU A 279 N CSD A 280 1555 1555 1.33
CISPEP 1 PRO A 225 PRO A 226 0 0.75
CISPEP 2 PRO A 420 PRO A 421 0 -0.10
SITE 1 AC1 11 LEU A 100 LYS A 101 VAL A 106 VAL A 179
SITE 2 AC1 11 TYR A 181 TYR A 188 PHE A 227 LEU A 234
SITE 3 AC1 11 HIS A 235 TYR A 318 GLU B 138
CRYST1 140.700 110.800 73.400 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007107 0.000000 0.000000 0.00000
SCALE2 0.000000 0.009025 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013624 0.00000
(ATOM LINES ARE NOT SHOWN.)
END